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Abstract
Background: Lack of antihypertensive use among hypertensive individuals is a major public health
problem. It remains unclear as to how much of this lack of treatment is because of failure to
diagnose hypertension or failure to initiate drug treatment for those with a diagnosis of
hypertension. The primary aim of this study was to determine the proportion of those untreated
individuals who would be recommended to start drug therapy for control of blood pressure among
those aware or unaware of their diagnosis of hypertension.
Methods: The Canadian Heart Health Surveys (1986 – 1992), a national, cross-sectional
descriptive survey (n = 23 129), was used to determine the proportion of individuals who were
untreated, yet satisfied the 2004 Canadian hypertension guidelines for initiating drug therapy.
Patients were divided into subgroups of those aware and unaware of having a diagnosis of
hypertension according to self reported awareness from the survey.
Results: Of those with untreated hypertension (= 140/90 mmHg), only 37% were aware of their
diagnosis. 74% of untreated individuals aware of their diagnosis of hypertension would require drug
therapy, compared to 57% of those who were unaware. Of those >65 years of age, 52% of aware
individuals needed drug therapy whereas only 34% of unaware elderly would need drug treatment.
Conclusion: In both unaware and aware subgroups, the majority of patients with untreated
hypertension would benefit from antihypertensive drug therapy according to the 2004 Canadian
Hypertension recommendations. The proportion of untreated patients that still need drug therapy
was higher among those who were aware compared to those who were unaware. This finding
suggests that the major gap in hypertension control may be in initiating drug therapy rather than in
diagnosing hypertension. Further studies are needed to confirm these results to ultimately help
strategize public health efforts in controlling hypertension.
Background
Antihypertensive drug therapy can reduce cardiovascular
morbidity and mortality by 25–30% [1-3] in those with
hypertension. The 2004 Canadian hypertension guide-
lines [4] recommend pharmacotherapy in those patients
where there is proven cardiovascular benefit from rand-
omized controlled trial evidence. However, many of these
'at risk' patients with hypertension remain untreated even
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[5]. This lack of treatment is a major public health prob-
lem as hypertension is a modifiable risk factor. It remains
unclear as to how much of this lack of treatment is
because of failure to diagnose hypertension or failure to
initiate drug treatment for those with a diagnosis of hyper-
tension. Further understanding would help to strategize
public health care initiatives in controlling high blood
pressure. The primary aim of this study was to determine
the proportion of those untreated individuals who would
be recommended to start drug therapy for control of
blood pressure among those aware or unaware of their
diagnosis of hypertension.
Methods
From the 2004 Canadian Hypertension Guidelines, phar-
macotherapy is recommended if the diastolic blood pres-
sure is > 100 mmHg; the systolic pressure is > 160 mmHg;
or the diastolic blood pressure is >90 mmHg in the pres-
ence of cardiovascular heart disease or risk factors. To
determine the proportions of individuals who satisfied
the guidelines for initiation of drug treatment for hyper-
tension, we used the Canadian Heart Health Surveys
(1986 – 1992). This national, cross-sectional descriptive
survey (n = 23 129) contains data on individual blood
pressure measurements using standardized technique as
well as information on cardiovascular risk profile, antihy-
pertensive medication use and self reported awareness of
hypertension. Further details of this survey have been
published elsewhere [6]. We then calculated for both
aware and unaware subgroups, the number of untreated
hypertensive individuals that would be recommended
drug therapy/ those untreated, hypertensive individuals.
Patients with diabetes mellitus were excluded from the
analysis because they require antihypertensive drug ther-
apy at a much lower threshold. Descriptive statistics were
used to calculate proportions and 95% confidence inter-
vals in this study.
Results
Of those with untreated hypertension (= 140/90 mmHg),
only 37% (n = 897 786) were aware of their diagnosis.
Among those aware and unaware of their diagnosis of
hypertension, 35% vs. 36% were female; 14% vs. 12%
had any cardiovascular disease and 31% vs. 75% were
under the age of 65 years respectively. The proportions of
those who would be recommended drug therapy among
those who are aware and unaware are presented in Table
1. Table 1 demonstrates that compared to the unaware
subgroup, a greater proportion of those aware of their
hypertensive status needed drug therapy but were
untreated. Among both aware and unaware groups, the
largest proportion needing drug therapy was less than age
65 years. Of note, among those who were unaware, there
was a considerably lower proportion that needed drug
therapy over the age of 65 years.
Discussion
In both unaware and aware subgroups, the majority of
patients with untreated hypertension would benefit from
antihypertensive drug therapy according to the 2004
Canadian Hypertension recommendations. This analysis
extends the findings from other studies [5,7,8] by deter-
mining those 'at risk' individuals that would be recom-
mended pharmacotherapy based on awareness of their
hypertensive status. The proportion of untreated patients
that still needed drug therapy was higher among those
who were aware compared to those who were unaware.
Specifically, among the elderly, most of the patients who
are unaware that they are hypertensive would not actually
be recommended to take drug therapy. These study find-
ings suggest that a significant gap in hypertension control
may be initiating drug therapy among those known to
have hypertension. Possible barriers to initiating drug
therapy may arise from patients, physicians [9] or the
health care system.
There are several limitations with this study. First, the
Canadian Heart Health Survey data are 12 years old and
there is some evidence to suggest that prescription rates of
antihypertensive drugs have improved since then [10].
However, this data set represents the best population data
available on patients with hypertension in Canada since it
is of high quality and captures a large cohort of Canadi-
ans. Another limitation is that the awareness or unaware-
ness of hypertensive status is based on self report and not
from physician records.
Table 1: Proportions of those aware and unaware who require drug therapy (95% CI)
Awareness of hypertensive status >65 years 18–64 years Total
Aware 71 477/ 138 342
51.7% (51.5–51.9%)
592 186/ 759 444
78% (77.9–78.1%)
663 663/ 897 786
73.9% (73.8–74%)
Unaware 129 398/ 376 861
34% (33.8–34.2%)
738 542/ 1 143 872
64.6% (64.5–64.7%)
867 940/ 1 520 733
57.1% (57–57.2%)Page 2 of 3
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This study found a considerable number of both unaware
and aware patients with untreated hypertension require
drug therapy. However, the majority of those who needed
drug therapy were actually aware that they had a diagnosis
of hypertension compared to those who were not aware.
This finding suggests that the major gap in hypertension
control may be in initiating drug therapy rather than in
diagnosing hypertension. Further studies are needed to
confirm these results to ultimately help strategize public
health efforts in controlling hypertension.
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